Skip to content

Non-invasive Positive Pressure Therapy in Sleep Apnea After Acute Myocardial Infarction – a health care delivery study

Non-invasive Positive Pressure Therapy in Sleep Apnea After Acute Myocardial Infarction – a health care delivery study - PainToVentilation

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00037217
Enrollment
110
Registered
2025-06-17
Start date
2025-07-18
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G47.3 I21

Interventions

Group 1: Patients with sleep-disordered breathing (SDB) (apnoea–hypopnoea index [AHI] =15/h) – newly initiated non-invasive positive pressure therapy (in accordance with guideline recommendations) Gro

Sponsors

Universitätsklinikum Regensburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: - ST-elevation myocardial infarction or non-ST-elevation myocardial infarction with complete occlusion of a coronary artery - Primarily successful percutaneous coronary intervention

Exclusion criteria

Exclusion criteria: - Indication for surgical revascularization - Cardiogenic shock - Left ventricular systolic function <30% - NYHA class IV - Contraindications to positive airway pressure support (mean blood pressure in supine position < 60 mmHg, inability to clear secretions, risk of aspiration of gastric contents, history of pneumothorax and/or pneumomediastinum, history of epistaxis leading to pulmonary aspiration of blood) - Patients receiving or requiring oxygen therapy - Mechanical ventilation - Pre-existing non-invasive ventilation or nocturnal positive pressure therapy - Pregnancy

Design outcomes

Primary

MeasureTime frame
Evaluation of the time to initiation of non-invasive positive pressure therapy after acute myocardial infarction

Secondary

MeasureTime frame
Difference in left ventricular function between patients over 12 weeks between the study groups

Countries

Germany

Contacts

Public ContactMichael Arzt

Universitätsklinikum Regensburg

michael.arzt@ukr.de0941-944-7210

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026